One cluster was enriched with genes predicted to be involved in biological processes related to tumor progression (e.g., E2F targets, G2/M checkpoint, and MYC targets), whereas two clusters were enriched for immunological processes (e.g., allograft rejection, complement, and interferon-γ response). The gene discussed is MYC; the disease is neoplasm.